Something in the works???? SEPR at 50.22

SEPR sentiment on a scale of one to ten this year has been a one. Now with the fortunate rejection of indiplon, unfortunate for nbix, the stock sentiment is now a 2. Analyst and investors are still skeptical Lunesta can meet its sales targets. Also, its other drug is losing some medicare coverage.

What is interesting is that Sepr has hung in there with bad news after bad news.. Now with the tides turning, I think many shorts will be surprised.. They haven't profited hand over fist like they imagined.

Something big is in the works? Who knows. But the way the stock is acting, Big news wouldn't be a shocker!

SEPR is a hold near term, but would definitely keep a close eye on this one.